Author:
Ikeda Takaya, ,Fukuda Minoru,Nakamura Yoichi,Kinoshita Akitoshi,Senju Hiroaki,Nakano Hirofumi,Kitazaki Takeshi,Ogawara Daiki,Taniguchi Hirokazu,Motoshima Kohei,Yamaguchi Hiroyuki,Nakatomi Katsumi,Shimada Midori,Nagashima Seiji,Tsukamoto Kazuhiro,Kohno Shigeru
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference29 articles.
1. Vital Statistics of Japan (Ministry of Health, Labour & Walfare)
2. Detterbeck FC (2000) Diagnosis and treatment of lung cancer, in an evidence-based guide for the practicing physician. WB Saunders, Philadelphia
3. Noda K, Nishiwaki Y, Kawahara M, Negoro S, Sugiura T, Yokoyama A, Fukuoka M, Mori K, Watanabe K, Tamura T, Yamamoto S, Saijo N (2002) Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346:85–91
4. Hanna N, Bunn PA Jr, Langer C, Einhorn L, Guthrie T Jr, Beck T, Ansari R, Ellis P, Byrne M, Morrison M, Hariharan S, Wang B, Sandler A (2006) Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 24:2038–2043
5. Lana PN Jr, Natale R, Crowley J, Lenz HJ, Redman MW, Carleton JE, Jett J, Langer CJ, Kuebler JP, Dakhil SR, Chansky K, Gandara DR (2009) Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomics results from SWOG S0124. J Clin Oncol 27:2530–2535
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献